Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial

Stephen A. Boorjian(Mayo Clinic in Arizona), Mehrdad Alemozaffar(Kaiser Permanente), Badrinath R. Konety(University of Minnesota), Neal D. Shore(Carolina Urologic Research Center), Leonard G. Gomella(Sidney Kimmel Cancer Center), Ashish M. Kamat(The University of Texas MD Anderson Cancer Center), Trinity J. Bivalacqua(Johns Hopkins Medicine), Jeffrey S. Montgomery(University of Michigan–Ann Arbor), Seth P. Lerner(Baylor College of Medicine), Joseph E. Busby(Prisma Health), Michael Poch(Moffitt Cancer Center), Paul L. Crispen(University of Florida), Gary D. Steinberg(NYU Langone Health), Anne Schuckman(University of Southern California), Tracy M. Downs(University of Wisconsin–Madison), Robert S. Svatek(The University of Texas Health Science Center at San Antonio), Joseph Mashni(The University of Texas MD Anderson Cancer Center), Brian R. Lane(Michigan State University), Thomas J. Guzzo(University of Pennsylvania), Gennady Bratslavsky(SUNY Upstate Medical University), Lawrence I. Karsh(The Urology Center of Colorado), Michael Woods(University of North Carolina at Chapel Hill), Gordon Brown(New Jersey Urology), Daniel Canter(Ochsner Health System), Adam Luchey(West Virginia University), Yair Lotan(The University of Texas Southwestern Medical Center), Tracey L. Krupski(University of Virginia Cancer Center), Brant A. Inman(Duke University), Michael B. Williams(Urology of Virginia), Michael S. Cookson(University of Oklahoma Health Sciences Center), Kirk A. Keegan(Vanderbilt University Medical Center), Gerald L. Andriole(Washington University in St. Louis), Alexander I. Sankin(Montefiore Medical Center), Alan Boyd(Boyds (United Kingdom)), Michael A. O’Donnell(University of Iowa), David G. Sawutz, Richard Philipson(Parker Hannifin (United Kingdom)), Ruth Coll(Parker Hannifin (United Kingdom)), Vikram M. Narayan(The University of Texas MD Anderson Cancer Center), F. Peter Treasure(Royal Statistical Society), Seppo Ylä‐Herttuala(University of Eastern Finland), Nigel Parker(University of Eastern Finland), Colin P. Dinney(The University of Texas MD Anderson Cancer Center)
The Lancet Oncology
November 27, 2020
Cited by 434Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis